Benzinga | Mar 16, 2021 04:03PM EDT

Cue Biopharma Q4 EPS $(0.37) Misses $(0.35) Estimate

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.35) by 5.71 percent. This is unchanged from the same period last year.